Adult Cardiac Progenitor Cell Aggregates Exhibit Survival Benefit Both In Vitro and In Vivo

Background: A major hurdle in the use of exogenous stems cells for therapeutic regeneration of injured myocardium remains the poor survival of implanted cells. To date, the delivery of stem cells into myocardium has largely focused on implantation of cell suspensions. Methodology and Principal Findi...

Full description

Bibliographic Details
Main Authors: Bauer, Michael, Kang, Lifeng, Qiu, Yiling, Peng, Michelle, Chen, Howard H., Camci-Unal, Gulden, Bayomy, Ahmad F., Sosnovik, David E., Khademhosseini, Ali, Liao, Ronglih
Other Authors: Harvard University--MIT Division of Health Sciences and Technology
Format: Article
Language:en_US
Published: Public Library of Science 2013
Online Access:http://hdl.handle.net/1721.1/77204
_version_ 1811075992864686080
author Bauer, Michael
Kang, Lifeng
Qiu, Yiling
Peng, Michelle
Chen, Howard H.
Camci-Unal, Gulden
Bayomy, Ahmad F.
Sosnovik, David E.
Khademhosseini, Ali
Liao, Ronglih
author2 Harvard University--MIT Division of Health Sciences and Technology
author_facet Harvard University--MIT Division of Health Sciences and Technology
Bauer, Michael
Kang, Lifeng
Qiu, Yiling
Peng, Michelle
Chen, Howard H.
Camci-Unal, Gulden
Bayomy, Ahmad F.
Sosnovik, David E.
Khademhosseini, Ali
Liao, Ronglih
author_sort Bauer, Michael
collection MIT
description Background: A major hurdle in the use of exogenous stems cells for therapeutic regeneration of injured myocardium remains the poor survival of implanted cells. To date, the delivery of stem cells into myocardium has largely focused on implantation of cell suspensions. Methodology and Principal Findings: We hypothesize that delivering progenitor cells in an aggregate form would serve to mimic the endogenous state with proper cell-cell contact, and may aid the survival of implanted cells. Microwell methodologies allow for the culture of homogenous 3D cell aggregates, thereby allowing cell-cell contact. In this study, we find that the culture of cardiac progenitor cells in a 3D cell aggregate augments cell survival and protects against cellular toxins and stressors, including hydrogen peroxide and anoxia/reoxygenation induced cell death. Moreover, using a murine model of cardiac ischemia-reperfusion injury, we find that delivery of cardiac progenitor cells in the form of 3D aggregates improved in vivo survival of implanted cells. Conclusion: Collectively, our data support the notion that growth in 3D cellular systems and maintenance of cell-cell contact improves exogenous cell survival following delivery into myocardium. These approaches may serve as a strategy to improve cardiovascular cell-based therapies.
first_indexed 2024-09-23T10:14:28Z
format Article
id mit-1721.1/77204
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T10:14:28Z
publishDate 2013
publisher Public Library of Science
record_format dspace
spelling mit-1721.1/772042022-09-26T16:39:57Z Adult Cardiac Progenitor Cell Aggregates Exhibit Survival Benefit Both In Vitro and In Vivo Bauer, Michael Kang, Lifeng Qiu, Yiling Peng, Michelle Chen, Howard H. Camci-Unal, Gulden Bayomy, Ahmad F. Sosnovik, David E. Khademhosseini, Ali Liao, Ronglih Harvard University--MIT Division of Health Sciences and Technology Wu, Jinhui Kang, Lifeng Wu, Jinhui Peng, Michelle Camci-Unal, Gulden Sosnovik, David E. Khademhosseini, Ali Background: A major hurdle in the use of exogenous stems cells for therapeutic regeneration of injured myocardium remains the poor survival of implanted cells. To date, the delivery of stem cells into myocardium has largely focused on implantation of cell suspensions. Methodology and Principal Findings: We hypothesize that delivering progenitor cells in an aggregate form would serve to mimic the endogenous state with proper cell-cell contact, and may aid the survival of implanted cells. Microwell methodologies allow for the culture of homogenous 3D cell aggregates, thereby allowing cell-cell contact. In this study, we find that the culture of cardiac progenitor cells in a 3D cell aggregate augments cell survival and protects against cellular toxins and stressors, including hydrogen peroxide and anoxia/reoxygenation induced cell death. Moreover, using a murine model of cardiac ischemia-reperfusion injury, we find that delivery of cardiac progenitor cells in the form of 3D aggregates improved in vivo survival of implanted cells. Conclusion: Collectively, our data support the notion that growth in 3D cellular systems and maintenance of cell-cell contact improves exogenous cell survival following delivery into myocardium. These approaches may serve as a strategy to improve cardiovascular cell-based therapies. 2013-02-27T15:13:23Z 2013-02-27T15:13:23Z 2012-11 2012-09 Article http://purl.org/eprint/type/JournalArticle 1932-6203 http://hdl.handle.net/1721.1/77204 Bauer, Michael et al. “Adult Cardiac Progenitor Cell Aggregates Exhibit Survival Benefit Both In Vitro and In Vivo.” Ed. Loren E. Wold. PLoS ONE 7.11 (2012). en_US http://dx.doi.org/10.1371/journal.pone.0050491 PLoS ONE Creative Commons Attribution http://creativecommons.org/licenses/by/2.5/ application/pdf Public Library of Science PLoS
spellingShingle Bauer, Michael
Kang, Lifeng
Qiu, Yiling
Peng, Michelle
Chen, Howard H.
Camci-Unal, Gulden
Bayomy, Ahmad F.
Sosnovik, David E.
Khademhosseini, Ali
Liao, Ronglih
Adult Cardiac Progenitor Cell Aggregates Exhibit Survival Benefit Both In Vitro and In Vivo
title Adult Cardiac Progenitor Cell Aggregates Exhibit Survival Benefit Both In Vitro and In Vivo
title_full Adult Cardiac Progenitor Cell Aggregates Exhibit Survival Benefit Both In Vitro and In Vivo
title_fullStr Adult Cardiac Progenitor Cell Aggregates Exhibit Survival Benefit Both In Vitro and In Vivo
title_full_unstemmed Adult Cardiac Progenitor Cell Aggregates Exhibit Survival Benefit Both In Vitro and In Vivo
title_short Adult Cardiac Progenitor Cell Aggregates Exhibit Survival Benefit Both In Vitro and In Vivo
title_sort adult cardiac progenitor cell aggregates exhibit survival benefit both in vitro and in vivo
url http://hdl.handle.net/1721.1/77204
work_keys_str_mv AT bauermichael adultcardiacprogenitorcellaggregatesexhibitsurvivalbenefitbothinvitroandinvivo
AT kanglifeng adultcardiacprogenitorcellaggregatesexhibitsurvivalbenefitbothinvitroandinvivo
AT qiuyiling adultcardiacprogenitorcellaggregatesexhibitsurvivalbenefitbothinvitroandinvivo
AT pengmichelle adultcardiacprogenitorcellaggregatesexhibitsurvivalbenefitbothinvitroandinvivo
AT chenhowardh adultcardiacprogenitorcellaggregatesexhibitsurvivalbenefitbothinvitroandinvivo
AT camciunalgulden adultcardiacprogenitorcellaggregatesexhibitsurvivalbenefitbothinvitroandinvivo
AT bayomyahmadf adultcardiacprogenitorcellaggregatesexhibitsurvivalbenefitbothinvitroandinvivo
AT sosnovikdavide adultcardiacprogenitorcellaggregatesexhibitsurvivalbenefitbothinvitroandinvivo
AT khademhosseiniali adultcardiacprogenitorcellaggregatesexhibitsurvivalbenefitbothinvitroandinvivo
AT liaoronglih adultcardiacprogenitorcellaggregatesexhibitsurvivalbenefitbothinvitroandinvivo